Caboz

Caboz is Cabozantinib, a multi-targeted tyrosine kinase inhibitor. It is indicated for renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid cancer and works by targeting kinases involved in tumor growth, metastasis, and angiogenesis.

Features